Immunome Q4 Adj EPS $(0.15) Beats $(0.28) Estimate, Sales $3.83M Beat $2.07M Estimate

benzinga_article
2024.03.29 03:37

Immunome（纳斯达克股票代码：IMNM）报告称，第四季度业绩好于预期，调整后的每股收益为-0.15 美元，超出了预期的-0.28 美元，增幅达 46.43%。销售额为 383 万美元，也超出了 207 万美元的预期，增幅达 84.83%

Immunome（纳斯达克股票代码：IMNM）报告每股亏损 0.15 美元，超过分析师预期的 0.28 美元，增幅达 46.43%。与去年同期每股亏损 0.64 美元相比，这是一个 76.56% 的增长。该公司季度销售额为 383 万美元，超过分析师预期的 207 万美元，增幅达 84.83%

Source: benzinga_article The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.